Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Type II Diabetes I: Introduction

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

Type II Diabetes II: Pathophysiology

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Type I Diabetes II: Pathophysiology

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Type I Diabetes III: Clinical Manifestations

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Preparation of Hydrophobic Au Catalyst and Application in One-Step Oxidative Esterification of Methacrolein to Methyl Methacrylate.

Molecules (Basel, Switzerland)·2024

Same author

Multiomics Analysis of PCB126's Effect on a Mouse Chronic-Binge Alcohol Feeding Model.

Environmental health perspectives·2024

Same author

Glucagon-like-peptide-1 receptor agonists and the management of type 2 diabetes-backwards and forwards.

World journal of diabetes·2024

Same author

Alzheimer's disease and low-dose radiation therapy: A new hope.

Radiation medicine and protection·2024

Same author

Excessive fat expenditure in MCT-induced heart failure rats is associated with BMAL1/REV-ERBα circadian rhythmic loop disruption.

Scientific reports·2024

Same author

Chronic Aroclor 1260 exposure alters the mouse liver proteome, selenoproteins, and metals in steatotic liver disease.

Environmental toxicology and pharmacology·2024

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

Diabetes and metallothionein.

Xiaokun Li¹, Lu Cai, Wenke Feng

¹Chinese-American Research Institute for Diabetic Complications, School of Pharmaceutical Sciences, The WenzhouMedical College, Wenzhou, Zhejiang, PR China.

Mini Reviews in Medicinal Chemistry

|July 14, 2007

Summary

Metallothionein (MT), a potent antioxidant, protects against diabetes and its complications. Enhanced MT expression, particularly with zinc, prevents diabetes development and organ damage, highlighting its therapeutic potential.

Related Experiment Videos

Last Updated: Jul 13, 2026

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Ion Mobility-Mass Spectrometry Techniques for Determining the Structure and Mechanisms of Metal Ion Recognition and Redox Activity of Metal Binding Oligopeptides

Published on: September 7, 2019

Area of Science:

Biochemistry
Cell Biology
Endocrinology

Background:

Diabetes mellitus is a prevalent metabolic disorder linked to increased oxidative stress and subsequent organ damage.
Metallothionein (MT) is an intracellular, cysteine-rich protein involved in metal homeostasis and cellular protection.
MT exhibits potent antioxidant properties, acting as an adaptive protein against oxidative stress.

Purpose of the Study:

To review the biochemical features of Metallothionein (MT).
To summarize the protective effects of MT against diabetes development and its complications.
To discuss the role of MT and zinc in preventing diabetes and related organ dysfunction.

Main Methods:

Literature review of studies investigating Metallothionein (MT) in diabetes.
Analysis of data on MT induction (genetic or pharmacologic) and its impact on diabetes.
Examination of MT's role in protecting organs like the pancreas, heart, and kidney from diabetic damage.

Main Results:

Zinc-induced or genetically enhanced MT synthesis in the pancreas prevented diabetes development.
Increased MT expression in organs like the heart and kidney protected against diabetes-induced dysfunction (cardiomyopathy, nephropathy).
MT acts as a significant antioxidant and adaptive protein, mitigating oxidative stress in diabetes.

Conclusions:

Metallothionein (MT) demonstrates significant potential in preventing diabetes onset and progression.
Enhanced MT expression, potentially coordinated with zinc, offers protection against diabetic complications.
MT's antioxidant and adaptive functions underscore its therapeutic relevance for diabetes management.